HRA Pharma

Perrigo Company plc is an American Irish–registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters in Grand Rapids, MI, within Michigan State University's Grand Rapids Innovation Park.

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Ella	Ulipristal	2010-08-13	2028-2030	Postcoital contraception , Leiomyoma
Ketoconazole	Ketoconazole	2014-11-18		Mycoses , Oral candidiasis , Vulvovaginal candidiasis , Seborrheic dermatitis , Cushing syndrome , Tinea pedis , Coccidioidomycosis , Tinea versicolor , Blastomycosis , Histoplasmosis , Cutaneous candidiasis , Leishmaniasis , Acanthamoeba keratitis , Chronic mucocutaneous candidiasis , Paracoccidioidomycosis
Levonorgestrel	Levonorgestrel	2018-07-03	2024-2040	Prostatic neoplasms , Breast neoplasms , Menorrhagia , Primary ovarian insufficiency , Hot flashes , Hypogonadism , Premature menopause
Lysodren	Mitotane	1982-01-01		Adrenal cortex neoplasms, Adrenocortical carcinoma, Cushing syndrome
Metopirone	Metyrapone	1982-01-01		—
Opill	Norgestrel	1982-01-01		Prostatic neoplasms, Breast neoplasms, Menorrhagia, Primary ovarian insufficiency, Hot flashes, Hypogonadism, Premature menopause
Ellaone	Ulipristal	2009-05-15	2028-2030	Postcoital contraception, Leiomyoma